Medline OncoEd Both
Main Menu

Oncology Stocks
AZN$39.56-1.03 (-2.54%)
NVS$48.98-0.56 (-1.13%)
SNY$31.11-1.58 (-4.83%)
GSK$36.38-0.59 (-1.6%)
CINV Information Center
Latest CINV News
Physicians and Nurses Underestimate the Incidence of Delayed Chemotherapy-Induced Nausea and Vomiting (5/13/2004)

Aloxi® Injection Incorporated into NCCN® antiemetic guidelines (3/30/2004)

Aloxi® Approved for Acute and Delayed Nausea and Vomiting (3/8/2004)

Aprepitant (Emend®) Decreases Nausea and Vomiting Due to Cisplatin-Based Chemotherapy (11/24/2003)

National Comprehensive Cancer Network Update on Anemia Includes Use of Aranesp® (11/5/2003)


More CINV News »
Submit an Editorial
CME
Newsletters
Register in our member center today to receive a monthly newsletter with clinical news, conference coverage, and current topic updates.
Learn More »
Current Topics

Strategies for Treating Chemotherapy-Induced Nausea and Vomiting
Steven M. Grunberg, MD - Professor of Medicine, University of Vermont College of Medicine

Status of Computerized Tomographic Colonoscopy (CTC)
John Klock, MD, co-founder and Chairman Holistica Hawaii; and C. Dean Buckner, MD, founding member Fred Hutchinson Cancer Research Center
Conference Coverage

Chemotherapy-Induced Nausea and Vomiting (CINV): An Update from ASCO 2004
David Ettinger, MD Professor of Oncology and Medicine, Associate Director for Clinical Research in the Oncology Center, Johns Hopkins

MASCC/ISOO 16th International Supportive Care in Cancer Symposium: Clinical Trial Results on the Safety and Efficacy of Aloxi®
C. D. Buckner, Medical Editorial Director, OncoEd

Chemotherapy-Induced Nausea and Vomiting: An Update from ONS 2004
C. D. Buckner, MD and Jennifer Maxon, RN

Past, Present and Future of Chemotherapy Induced Nausea and Vomiting (ONS 2003)
Additional Resources
Information by Cancer Type



© 1998-2007 OncoEd, Inc.   All Rights Reserved.